ES2096663T3 - Agente terapeutico para lesiones de la cornea. - Google Patents
Agente terapeutico para lesiones de la cornea.Info
- Publication number
- ES2096663T3 ES2096663T3 ES91919156T ES91919156T ES2096663T3 ES 2096663 T3 ES2096663 T3 ES 2096663T3 ES 91919156 T ES91919156 T ES 91919156T ES 91919156 T ES91919156 T ES 91919156T ES 2096663 T3 ES2096663 T3 ES 2096663T3
- Authority
- ES
- Spain
- Prior art keywords
- cornea
- therapeutic agent
- injuries
- activation
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000028006 Corneal injury Diseases 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 229940124597 therapeutic agent Drugs 0.000 title abstract 3
- 230000004913 activation Effects 0.000 abstract 2
- 230000000144 pharmacologic effect Effects 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 102000010445 Lactoferrin Human genes 0.000 abstract 1
- 108010063045 Lactoferrin Proteins 0.000 abstract 1
- 108010023244 Lactoperoxidase Proteins 0.000 abstract 1
- 102000045576 Lactoperoxidases Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 abstract 1
- 229940078795 lactoferrin Drugs 0.000 abstract 1
- 235000021242 lactoferrin Nutrition 0.000 abstract 1
- 229940057428 lactoperoxidase Drugs 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/832—Milk; colostrum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
UN AGENTE TERAPEUTICO PARA LESION DE CORNEA CONTIENE LACTOFERRINA Y/O LACTOPEROXIDASA COMO INGREDIENTE ACTIVO. AMBAS SON PROTEINAS CONTENIDAS EN LA LECHE Y AGRIMAS HUMANAS BOVINAS ETC., Y TIENEN UNA ACTIVIDAD ANTIBACTERIAL Y FARMACOLOGICA TAL COMO LA ACTIVACION DEL CRECIMIENTO DE LIMPOCITOS, Y NO HAN SIDO A PENAS APLICADAS AL CAMPO OFTALMOLOGICO. LA INVENCION ESTA BASADA EN QUE TIENEN UNA NUEVA ACTIVIDAD FARMACOLOGICA APLICABLE A ESTE CAMPO Y QUE SON UTILES COMO AGENTES TERAPEUTICOS PARA LESIONES DE CORNEA, PORQUE TIENEN UNA EXCELENTE ACTIVIDAD DE ACTIVACION DEL CRECIMIENTO DE LAS CELULAS PARENQUIMALES DE LA CORNEA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30803690 | 1990-11-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2096663T3 true ES2096663T3 (es) | 1997-03-16 |
Family
ID=17976118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES91919156T Expired - Lifetime ES2096663T3 (es) | 1990-11-13 | 1991-11-08 | Agente terapeutico para lesiones de la cornea. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5561109A (es) |
| EP (1) | EP0579830B1 (es) |
| JP (1) | JP2840795B2 (es) |
| AT (1) | ATE148631T1 (es) |
| DE (1) | DE69124627T2 (es) |
| DK (1) | DK0579830T3 (es) |
| ES (1) | ES2096663T3 (es) |
| GR (1) | GR3023080T3 (es) |
| WO (1) | WO1992008477A1 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07196529A (ja) * | 1993-12-29 | 1995-08-01 | Morinaga Milk Ind Co Ltd | 創傷治癒剤、化粧料および養毛剤 |
| JP3118584B2 (ja) | 1995-05-08 | 2000-12-18 | 参天製薬株式会社 | 術後乱視予防剤 |
| JPH1149698A (ja) | 1997-07-31 | 1999-02-23 | Santen Pharmaceut Co Ltd | 安定性を向上させたラクトフェリンの水性製剤 |
| US6399570B1 (en) * | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
| US20030203839A1 (en) * | 1999-10-29 | 2003-10-30 | Kruzel Marian L. | Immune enhancing composition containing lactoferrin |
| US6613741B2 (en) * | 1999-10-29 | 2003-09-02 | Ferro Dynamics, Inc. | Method for treating aseptic SIRS in humans and other animals |
| AU2001236114A1 (en) * | 2000-05-29 | 2001-12-11 | Wakamoto Pharmaceutical Co., Ltd. | Remedies for corneal injuries |
| SE0200667D0 (sv) * | 2002-03-05 | 2002-03-05 | A & Science Invest Ab | Novel use of cytokine inhibitors |
| DK2298338T3 (da) * | 2002-09-16 | 2012-09-24 | Agennix Inc | Lactoferrin-sammensætninger og fremgangsmåder til behandling af hudsår |
| JP4795021B2 (ja) * | 2002-12-06 | 2011-10-19 | エイジェニックス インコーポレイテッド | 敗血症治療における経口用ラクトフェリン |
| US7323443B2 (en) * | 2002-12-12 | 2008-01-29 | Agennix Inc. | Lactoferrin in the reduction of pain |
| NZ537089A (en) | 2003-02-24 | 2007-07-27 | Morinaga Milk Industry Co Ltd | Interleukin 6 production inhibitor |
| CN100480378C (zh) | 2004-02-17 | 2009-04-22 | 森永乳业株式会社 | 生产乳过氧化物酶的方法 |
| US20070059300A1 (en) * | 2005-09-12 | 2007-03-15 | Zoltan Laboratories Llc | Compounds and compositions to control abnormal cell growth |
| WO2007055760A2 (en) * | 2005-10-31 | 2007-05-18 | Essential Skincare, Llc | Protein composition for promoting wound healing and skin regeneration |
| AU2011274244A1 (en) * | 2010-07-01 | 2013-01-10 | Brien Holden Vision Institute | Lactoferrin sequences, compositions and methods of corneal wound treatment |
| US10966948B2 (en) | 2019-07-23 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| BR112021000724A2 (pt) | 2018-07-27 | 2021-04-13 | Johnson & Johnson Surgical Vision, Inc. | Composições e métodos para tratar os olhos |
| US11969454B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
| US20250230406A1 (en) * | 2022-03-31 | 2025-07-17 | The Doshisha | Corneal endothelial cell preparation containing no culture-derived component, and method for producing same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2460135A1 (fr) * | 1979-07-02 | 1981-01-23 | Liotet Serge | Composition a usage externe a base de colostrum |
| LU85479A1 (fr) * | 1984-07-25 | 1986-02-12 | Oleofina Sa | Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer |
| US4745100A (en) * | 1985-05-14 | 1988-05-17 | Eye Research Institute Of Retina Foundation | Stimulation of tear secretion |
| FR2600250B1 (fr) * | 1986-06-23 | 1989-11-24 | Bio Serae | Procede pour conditionner une composition antibacterienne et composition antibacterienne conditionnee |
| JPH0248534A (ja) * | 1988-07-28 | 1990-02-19 | Bio Serae Sa:Soc | 抗菌組成物の配合方法及び配合された抗菌組成物 |
-
1991
- 1991-11-08 DK DK91919156.9T patent/DK0579830T3/da active
- 1991-11-08 JP JP3517447A patent/JP2840795B2/ja not_active Expired - Fee Related
- 1991-11-08 DE DE69124627T patent/DE69124627T2/de not_active Expired - Fee Related
- 1991-11-08 AT AT91919156T patent/ATE148631T1/de not_active IP Right Cessation
- 1991-11-08 EP EP91919156A patent/EP0579830B1/en not_active Expired - Lifetime
- 1991-11-08 ES ES91919156T patent/ES2096663T3/es not_active Expired - Lifetime
- 1991-11-08 WO PCT/JP1991/001539 patent/WO1992008477A1/ja not_active Ceased
-
1995
- 1995-04-21 US US08/426,635 patent/US5561109A/en not_active Expired - Fee Related
-
1997
- 1997-04-08 GR GR970400748T patent/GR3023080T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0579830A4 (en) | 1993-10-06 |
| EP0579830B1 (en) | 1997-02-05 |
| DE69124627T2 (de) | 1997-06-12 |
| WO1992008477A1 (fr) | 1992-05-29 |
| GR3023080T3 (en) | 1997-07-30 |
| ATE148631T1 (de) | 1997-02-15 |
| EP0579830A1 (en) | 1994-01-26 |
| JP2840795B2 (ja) | 1998-12-24 |
| DK0579830T3 (da) | 1997-08-18 |
| US5561109A (en) | 1996-10-01 |
| DE69124627D1 (de) | 1997-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Goldenheim | An appraisal of povidone-iodine and wound healing | |
| NO20003607D0 (no) | Insekticid med terpen for Õ drepe lus og luseegg | |
| DE69124627D1 (de) | Therapeutische agens bei hornhautverletzungen | |
| BR9407560A (pt) | Copolimeros elastômeros termoplásticos enxertados com silicone e composiçoes para tratamento dos cabelos e da pele contendo estes copolimeros | |
| DE69910210D1 (de) | Implantierbare medizinische vorrichtung mit antiinfektiösen und kontrazeptiven eigenschaften | |
| ATE185578T1 (de) | Thermoplastische und elastomere silikonpfropfcopolymere und diese enthaltende haar- und hautpflegemittel | |
| MX9504415A (es) | Eteres antivirales de isoesteres de sustrato de proteasa de aspartato. | |
| DE69424546D1 (de) | Thermoplastische elastomere copolymere und diese enthaltendes haar- und hautpflegemittel | |
| ES2227684T3 (es) | Albumina como ingrediente activo para el tratamiento de lesiones conjuntivas y de la cornea y del ojo seco. | |
| DK0492614T3 (da) | Epitheliocytvækstaccelerator | |
| DE60018409D1 (de) | Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren | |
| ES2143467T3 (es) | Agente terapeutico para el tratamiento de las heridas. | |
| Pietrogrande et al. | Short-term evaluation of synovectomy in haemophilia | |
| Reading | Secretan's syndrome: hard edema of the dorsum of the hand | |
| Alford et al. | Equine distal limb wounds: new and emerging treatments | |
| Köhler et al. | Bacteria on stumps of amputees and the effect of antiseptics | |
| DE60043886D1 (de) | Formulierungen mit povidon-iod zur behandlung von wunden | |
| ATE185274T1 (de) | Therapeutisches mittel gegen drohenden abortus | |
| Bayley | Wound healing in the patient with burns | |
| Barnes | Skin health and stump hygiene | |
| ES2182840T3 (es) | Factor xiii para el tratamiento de heridas de la piel. | |
| MARTIN et al. | The use of synthetic “skin” in lieu of homografts in the treatment of extensive third-degree burns | |
| Trotter | Principles of early wound management | |
| Hunter | A severe and extensive burn treated with solution of tannic acid | |
| Modaie | Use of Experimental Models During Bone and Joint Infections. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 579830 Country of ref document: ES |